As core biomaterials widely applied in biopharmaceuticals, vaccine development, diagnostic reagents and industrial enzyme manufacturing, recombinant proteins are persistently plagued by structural fragmentation and degradation throughout expression, purification, storage and end-to-end transportation during industrialization. Such stability defects directly lead to reduced biological activity, compromised batch-to-batch quality consistency, escalated production costs stemming from low yields, and even impaired clinical efficacy and potential biosafety risks in severe cases. This has become a common technical bottleneck restricting the research, development and large-scale commercialization of high-end recombinant protein products.
Tracing origins from molecular mechanisms, this paper systematically sorts out endogenous and exogenous triggers for recombinant protein fragmentation and degradation across all dimensions. It integrates multi-dimensional synergistic solutions ranging from rational protein design and host cell engineering to full-process process optimization and tailored formulation development. Meanwhile, a high-precision analytical toolkit for stability characterization is summarized, providing a comprehensive technical reference framework for the industry to address challenges related to recombinant protein stability.
1. Introduction: Stability Challenges from a Quality Perspective
The efficacy and safety of recombinant protein therapeutics rely heavily on the structural integrity and homogeneity of protein molecules. Nevertheless, throughout the workflow from gene expression to end-use application, recombinant proteins are continuously exposed to various potential stressors, triggering peptide chain cleavage, chemical modification of amino acid side chains, non-native aggregation and domain dissociation. These structural impairments not only attenuate target biological functions, but may also elicit host immune responses, substantially raising costs for process development and quality control. Unravelling the intrinsic driving forces behind degradation and fragmentation and establishing effective inhibition systems has become an essential prerequisite for the maturation of protein biotechnology.
2. Molecular Logic of Degradation and Fragmentation: Origins and Mechanism Analysis
Degradation and fragmentation of recombinant proteins are predominantly manifested as peptide bond cleavage, side-chain modification, aggregate dissociation and domain separation, with breakage frequently occurring at the N-terminus, mid-region or C-terminus of the polypeptide chain. Root causes can be categorized into four dimensions as follows:
2.1 Fundamental Mechanisms
During expression, incomplete folding or overexpression renders recombinant proteins susceptible to non-specific hydrolysis by endogenous proteases. In addition, abnormal post-translational modifications including oxidation, aberrant glycosylation and deamidation disrupt native protein conformation and initiate degradation. Physical stresses such as agitation and temperature/pH shocks can directly trigger structural fragmentation or aggregation-mediated inactivation. Flexible regions or repetitive sequences within amino acid sequences often constitute structural vulnerable sites prone to multimer dissociation.
2.2 Molecular Origins of Structural Fragility
The intrinsic amino acid sequence and three-dimensional architecture determine the baseline stability of a protein molecule and predetermine its susceptibility to degradation:
Primary sequence hotspots: Specific dipeptide motifs, such as Asp-Pro and Asn-Gly, are prone to hydrolysis or deamidation under physiological conditions. Methionine, cysteine and tryptophan residues are highly susceptible to oxidation, and their modified products often act as initiation sites for fragmentation events.
Higher-order structural defects: Domains with low thermodynamic stability (low melting temperature Tₘ, high folding free energy) undergo unfolding upon mild perturbations. Exposed hydrophobic patches and unpaired cysteine residues not only induce aggregation, but also disrupt native topological structures via mismatched disulfide bonds or oxidative crosslinking. Intrinsically disordered regions and flexible linkers serve as preferential attack sites for proteases.
2.3 Multiple Attacks from External Stressors
Environmental conditions impose destructive effects on proteins at multiple scales:
Physical stress: Shear force and interfacial tension generated by stirring, pumping and freeze-thaw cycles induce partial protein denaturation at gas-liquid or solid-liquid interfaces. Temperature fluctuations and water molecular rearrangement during lyophilization and reconstitution also disturb delicate conformational equilibrium.
Chemical stress: Buffer systems deviating from optimal pH accelerate acid/base-catalyzed peptide bond hydrolysis and deamidation kinetics. Dissolved oxygen, transition metal ions and light-stimulated reactive oxygen species selectively oxidize susceptible residues; reducing environments compromise disulfide bond integrity.
Biological stress: Trace residual host proteases exert potent degradative effects even at ultra-low concentrations, while exogenous protease systems derived from microbial contamination pose more severe biological threats.
2.4 Expression Systems: The First Barrier for Stability
Selection of the expression host fundamentally shapes protein stability at the source:
Prokaryotic systems (e.g., Escherichia coli): Despite high productivity, prokaryotes lack eukaryotic post-translational modification machinery, leading to inefficient disulfide bond formation and folding, and facilitating inclusion body formation. High expression rates further exacerbate misfolding and expose cleavage-prone regions to hydrolysis.
Eukaryotic systems (e.g., CHO cells, yeast): Eukaryotic hosts provide a near-native folding microenvironment and glycosylation modification to preserve conformational fidelity, yet they feature prolonged cultivation cycles and relatively limited yields. Moreover, vector design (promoter strength, signal peptide matching) and fusion tags (GST, His-tag) may introduce steric hindrance or additional protease cleavage sites, acting as potential sources of instability.
3. Full-Lifecycle Synergistic Strategies for Stability Enhancement
To mitigate degradation and fragmentation risks of recombinant proteins covering the whole workflow from molecular design, intracellular expression and downstream purification to final-product storage, multi-dimensional synergistic intervention strategies are required to mitigate destabilizing factors at the root.
3.1 Molecular Remodeling and Host Cell Engineering
Rational gene-level design fundamentally reinforces protein structural robustness:
Rational mutagenesis: Site-directed substitution of oxidation-sensitive residues (e.g., Met→Leu) or deamidation-prone sites (e.g., Asn→Gln), combined with mutations that strengthen hydrogen bond networks and salt bridges, can markedly improve thermodynamic stability.
Fusion partners and terminal protection: Solubility-enhancing tags including SUMO, Trx and MBP not only improve soluble expression, but also exert a molecular shielding effect to resist protease attack. N-terminal acetylation and C-terminal amidation block terminal charges and reduce exoprotease activity.
Backbone cyclization: Genetic engineering or chemical-mediated protein cyclization increases conformational rigidity and significantly improves anti-proteolytic capacity.
Host strain modification: Protease-deficient strains or cell lines with targeted endogenous protease gene knockout can be adopted. Co-expression of molecular chaperones (GroEL/ES, DnaK/DnaJ) or folding enzymes (PDI) creates a cytocompatible microenvironment to facilitate correct folding and eliminate degradation risks. Codon optimization coordinates translation elongation rates and reduces ribosome collision and misfolding.
3.2 Process Development: A Philosophy of Mild and Precise Operation
Expression regulation: Low-temperature induction reduces protein synthesis rates to allow sufficient time for nascent polypeptide folding. Optimizing inducer concentration and fed-batch strategies maintains metabolic homeostasis and avoids cellular stress triggered by nutrient depletion or accumulation of metabolic byproducts.
Purification processes: Mild cell lysis techniques (high-pressure homogenization, enzymatic lysis) shorten the exposure time of target proteins in crude extracts. During chromatographic separation, pH gradients and elution conditions should be carefully selected. Protease inhibitors can be supplemented (with subsequent complete removal guaranteed), and high-resolution media are adopted to minimize conformational perturbation caused by non-specific adsorption.
3.3 Formulation Development and Storage: The Final Defense Against Time and Environmental Stress
Excipient screening: Buffer systems with optimal pH buffering capacity are selected. Osmoprotectants such as sucrose and trehalose stabilize protein hydration shells; amino acids including arginine and proline exert dual functions of aggregation inhibition and antioxidation. Low-concentration polysorbate surfactants compete for gas-liquid interfaces to prevent interfacial denaturation.
Physical form selection: Liquid formulations require strict cold chain management throughout storage; lyophilized formulations drastically slow down chemical reaction rates via water removal. Appropriate lyoprotectants (mannitol, dextran) and optimized lyophilization cycles must be screened to avoid ice crystal-induced damage.
Standardized protection protocols: Operations should be performed under light protection and inert gas purging; small-volume aliquoting is recommended. Rigorous transportation specifications are established to avoid violent shaking.
4. High-Precision Analytical Toolkit for Stability Characterization
Accurate monitoring and localization of degradation processes constitute the prerequisite for effective intervention. Modern analytical technologies have formed a multi-layered characterization system:
Separation and preliminary screening: SDS-PAGE and size-exclusion chromatography (SEC) rapidly evaluate fragmentation and aggregation levels. Ion-exchange chromatography (IEX) and capillary electrophoresis (CE) achieve high-resolution separation of charge variants (e.g., deamidated products).
Precise localization of cleavage sites: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) based peptide mapping serves as the gold standard for identifying exact residues at peptide bond cleavage sites, and simultaneously characterizes heterogeneity arising from oxidation, glycation and other modifications.
Conformational and colloidal stability assessment: Circular dichroism (CD) and Fourier-transform infrared spectroscopy (FTIR) monitor secondary structural changes. Intrinsic fluorescence spectroscopy and differential scanning calorimetry (DSC) report tertiary structural microenvironment and thermal transition temperature (Tₘ), respectively. Dynamic/static light scattering (DLS/SLS) tracks aggregation kinetics in real time.
Accelerated predictive studies: Stress degradation tests under elevated temperature, light exposure, extreme pH, oxidative stress and repeated freeze-thaw conditions rapidly reveal potential vulnerable regions of proteins, providing prior data for formulation screening and process improvement.
5. Conclusion
Degradation and fragmentation of recombinant proteins during development and large-scale manufacturing arise from the combined effects of intrinsic sequence-dependent structural weaknesses, expression host characteristics, processing stresses and external environmental factors. Systematic identification of degradation mechanisms under different scenarios, clarification of specific peptide cleavage pathways, and development of targeted engineering solutions covering the full workflow from molecular design to manufacturing are critical to improving the quality of recombinant protein products.
At present, multi-dimensional strategies including rational protein engineering, directed host cell modification, refined purification process optimization and tailored formulation development have achieved remarkable outcomes in the development of multiple blockbuster recombinant protein products. Meanwhile, with rapid advances in high-resolution mass spectrometry, microcalorimetry and structural spectroscopy, dynamic monitoring of protein degradation and accurate quantification of trace degradation products become increasingly precise. Integrated application of multi-dimensional synergistic intervention strategies and high-precision characterization techniques is emerging as the core approach for the industry to overcome protein fragmentation and degradation challenges, and will continuously drive the research and industrialization of more high-quality protein therapeutics.
